Perioperative management for the prevention of postoperative pneumonia with esophageal surgery

Annals of Thoracic and Cardiovascular Surgery

Volumn 15, Issue 5, 2009, Pages 280-285

  Akutsu, Yasunori ^a   Matsubara, Hisahiro ^a  

^a CHIBA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

LEUKOCYTE ELASTASE INHIBITOR; STEROID;

ESOPHAGUS RESECTION; ESOPHAGUS TUMOR; HUMAN; MINIMALLY INVASIVE SURGERY; MORTALITY; MOUTH HYGIENE; PNEUMONIA; PREOPERATIVE CARE; REVIEW; RISK FACTOR; SMOKING; SMOKING CESSATION; TOOTH PLAQUE; TREATMENT OUTCOME;

DENTAL PLAQUE; ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; HUMANS; ORAL HYGIENE; PNEUMONIA; PREOPERATIVE CARE; PROTEINASE INHIBITORY PROTEINS, SECRETORY; RISK FACTORS; SMOKING; SMOKING CESSATION; STEROIDS; SURGICAL PROCEDURES, MINIMALLY INVASIVE; TREATMENT OUTCOME;

EID: 72049092940     PISSN: 13411098     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (75)

1. Isono K, Ochiai T, Okuyama K, Onoda S. The treatment of lymph node metastasis from esophageal cancer by extensive lymphadenectomy. J pn J Surg 1990;20:151-7.
2. Isono K, Sato H, Nakayama K. Results of a nationwide study on the three-field lymph node dissection of esophageal cancer. Oncology 1991;48:411-20.
3. Dapri G, Himpens J, Cadière GB. Minimally invasive esophagectomy for cancer: laparoscopic transhiatal procedure or thoracoscopy in prone position followed by laparoscopy? Surg Endosc 2008;22:1060-9.
4. Gemmill EH, McCulloch P. Systematic review of minimally invasive resection for gastro-oesophageal cancer. Br J Surg 2007;94:1461-7.
5. Jobe BA, Kim CY, Minjarez RC, O'Rourke R, Chang EY, et al. Simplifying minimally invasive transhiatal esophagectomy with the inversion approach: Lessons learned from the first 20 cases. Arch Surg 2006;141:857-66.
6. Scheepers JJ, Mulder CJ, Van Der Peet DL, Meijer S, Cuesta MA. Minimally invasive oesophageal resection for distal oesophageal cancer: a review of the literature. Scand J Gastroenterol Suppl; 2006:123-34.
7. Akutsu Y, Matsubara H, Shuto K, Uesato M, Mori M, et al. Clinical and pathologic evaluation of the effectiveness of neoadjuvant chemoradiation therapy in advanced esophageal cancer patients. World J Surg 2009;33:1002-9.
8. Greer SE, Goodney PP, Sutton JE, Birkmeyer J D. Neoadjuvant chemoradiotherapy for esophageal carcinoma: a meta-analysis. Surgery 2005;137:172-7.
9. Fiorica F, Di Bona D, Schepis F, Licata A, Shahied L, et al. Preoperative chemoradiotherapy for oesophageal cancer: a systematic review and meta-analysis. Gut 2004;53:925-30.
10. Urschel JD, Vasan H. A meta-analysis of randomized controlled trials that compared neoadjuvant chemoradiation and surgery to surgery alone for resectable esophageal cancer. Am J Surg 2003;185:538-43.
11. Kaklamanos IG, Walker GR, Ferry K, Franceschi D, Livingstone AS. Neoadjuvant treatment for resectable cancer of the esophagus and the gastroesophageal junction: a meta-analysis of randomized clinical trials. Ann Surg Oncol 2003;10:754-61.
12. Murthy SC, Rozas MS, Adelstein DJ, Mason D P, Calhoun R, et al. Induction chemoradiotherapy increases pleural and pericardial complications after esophagectomy for cancer. J Thorac Oncol 2009;4:395-403.
13. Matsubara H. Neoadjuvant chemoradiation therapy for the treatment of esophageal carcinoma. Int J Clin Oncol 2008;13:474-8.
14. Whooley BP, Law S, Murthy SC, Alexandrou A, Wong J. Analysis of reduced death and complication rates after esophageal resection. Ann Surg 2001;233:338-44.
15. Atkins BZ, Shah AS, Hutcheson KA, Mangum JH, Pappas TN, et al. Reducing hospital morbidity and mortality following esophagectomy. Ann Thorac Surg 2004;78:1170-6.
16. Kuwano H, Nishimura Y, Ohtsu A, Kato H, Kitagawa Y, et al. Guidelines for diagnosis and treatment of carcinoma of the esophagus April 2007 edition: part I. Esophagus 2008;5:61-73.
17. Kuwano H, Nishimura Y, Ohtsu A, Kato H, Kitagawa Y, et al. Guidelines for diagnosis and treatment of carcinoma of the esophagus April 2007 edition: part II. Esophagus 2008;5:117-32.
18. Schwilk B, Bothner U, Schraag S, Georgieff M. Perioperative respiratory events in smokers and nonsmokers undergoing general anaesthesia. Acta Anaesthesiol Scand 1997;41:348-55.
19. Ferguson MK, Durkin AE. Preoperative prediction of the risk of pulmonary complications after esophagectomy for cancer. J Thorac Cardiovasc Surg 2002;123:661-9.
20. Wightman JA. A prospective survey of the incidence of postoperative pulmonary complications. Br J Surg 1968;55:85-91.
21. 2 during anaesthesia and years of smoking predict late postoperative hypoxaemia and complications after upper abdominal surgery in patients without preoperative cardiopulmonary dysfunction. Acta Anaesthesiol Scand 2000;44:9-16.
22. Smetana GW. Preoperative pulmonary evaluation. N Engl J Med 1999;1340:937-44.
23. Bluman LG, Mosca L, Newman N, Simon DG. Preoperative smoking habits and postoperative pulmonary complications. Chest 1998;113:883-9.
24. Barrera R, Shi W, Amar D, Thaler H T, Gabovich N, et al. Smoking and timing of cessation: impact on pulmonary complications after thoracotomy. Chest 2005;127:1977-83.
25. Herdy AH, Marcchi PL, Vila A, Tavares C, Collaço J, et al. Pre-and postoperative cardiopulmonary rehabilitation in hospitalized patients undergoing coronary artery bypass surgery: a randomized controlled trial. Am J Phys Med Rehabil 2008;87:714-9.
26. Rochester CL. Pulmonary rehabilitation for patients who undergo lung-volume-reduction surgery or lung transplantation. Respir Care 2008;53:1196-202.
27. Reeve JC, Nicol K, Stiller K, McPherson KM, Denehy L. Does physiotherapy reduce the incidence of postoperative complications in patients following pulmonary resection via thoracotomy? a protocol for a randomised controlled trial. J Cardiothorac Surg 2008;3:48.
28. Chumillas S, Ponce JL, Delgado F, Viciano V, Mateu M. Prevention of postoperative pulmonary complications through respiratory rehabilitation: a controlled clinical study. Arch Phys Med Rehabil 1998;79:5-9.
29. Fagevik Olsén M, Hahn I, Nordgren S, Lönroth H, Lundholm K. Randomized controlled trial of prophylactic chest physiotherapy in major abdominal surgery. Br J Surg 1997;84:1535-8.
30. Nakatsuchi T, Otani M, Osugi H, Ito Y, Koike T. The necessity of chest physical therapy for thoracoscopic oesophagectomy. J Int Med Res 2005;33:434-41.
31. Sona CS, Zack JE, Schallom ME, McSweeney M, McMullen K, et al. The impact of a simple, low-cost oral care protocol on ventilator-associated pneumonia rates in a surgical intensive care unit. J Intensive Care Med 2009;24:54-62.
32. Fields LB. Oral care intervention to reduce incidence of ventilator-associated pneumonia in the neurologic intensive care unit. J Neurosci Nurs 2008;40:291-8.
33. Frost P, Wise M P. Tracheotomy and ventilator-associated pneumonia: the importance of oral care. Eur Respir J 2008;31:221-2.
34. Powers J, Brower A, Tolliver S. Impact of oral hygiene on prevention of ventilator-associated pneumonia in neuroscience patients. J Nurs Care Qual 2007;22:316-21.
35. Scannapieco FA, Mylotte JM. Relationships between per iodontal disease and bacterial pneumonia. J Periodontol 1996;67:1114-22.
36. Scannapieco FA, Stewart EM, Mylotte JM. Colonization of dental plaque by respiratory pathogens in medical intensive ca re patients. Crit Care Med 1992;20:740-5.
37. Fourrier F, Duvivier B, Boutigny H, Roussel-Delvallez M, Chopin C, et al. Colonization of dental plaque: a source of nosocomial infections in intensive ca re un it patients. Crit Care Med 1998;26:301-8.
38. Sumi Y, Miura H, Michiwaki Y, Nagaosa S, Nagaya M. Colonization of dental plaque by respiratory pathogens in dependent elderly. Arch G ero nt ol G eriatr 2007;44:119-24.
39. Akutsu Y, Matsubara H, Okazumi S, Shimada H, Shuto K, et al. Impact of preoperative dental plaque culture for predicting postoperative pneumonia in esophageal cancer patients. Dig Surg 2008;25:93-7.
40. Farran L, Llop J, Sans M, Kreisler E, Miró M, et al. Efficacy of enteral decontamination in the prevention of a nastomotic dehiscence and pulmonary infection in esoph - agogastric surgery. Dis Esophagus 2008;21:159-64.
41. Paju S, Scannapieco FA. Oral biofilms, periodontitis, and pulmonary infections. Oral Dis 2007;13:508-12.
42. Ford SJ. The importance and provision of oral hygiene in surgical patients. Int J Surg 2008;6:418-9.
43. Cruickshank AM, Fraser WD, Burns HJ, Van Damme J, Shenkin A. Response of serum interleukin-6 in patients undergoing elective surgery of varying severity. Clin Sci (Lond) 1990;79:161-5.
44. Biffl WL, Moore EE, Moore FA, Peterson VM. Interleukin-6 in the injured patient. Marker of injury or mediator of inf lammation? Ann Surg 1996;224:647-64.
45. Sauerland S, Nagelschmidt M, Mallmann P, Neugebauer EA. Risks and benefits of preoperative high dose methylprednisolone in surgical patients: a systematic review. Drug Saf 2000;23:449-61.
46. Matsutani T, Onda M, Sasajima K, Miyashita M. Glucocorticoid attenuates a decrease of antithrombin III following major surgery. J Surg Res 1998;79:158-63.
47. Shimada H, Ochiai T, Okazumi S, Matsubara H, Nabeya Y, et al. Clinical benefits of steroid therapy on surgical stress in patients with esophageal cancer. Surgery 2000;128:791-8.
48. Sato N, Koeda K, Ikeda K, Kimura Y, Aoki K, et al. Randomized study of the benefits of preoperative corticosteroid administration on the postoperative morbidity and cytokine response in patients undergoing surgery for esophageal cancer. Ann Surg 2002;236:184-90.
49. Yano M, Taniguchi M, Tsujinaka T, Fujiwara Y, Yasuda T, et al. Is preoperative methylprednisolone beneficial for patients undergoing esophagectomy? Hepatogastroenterology 2005;52:481-5.
50. Tsukada K, Miyazaki T, Katoh H, Masuda N, Fukuchi M, et al. Effect of perioperative steroid therapy on the postoperative course of patients with oesophageal cancer. Dig Liver Dis 2006;38:240-4.
51. Tsukada K, Hasegawa T, Miyazaki T, Katoh H, Yoshikawa M, et al. Predictive value of interleukin-8 and granulocyte elastase in pulmonary complication after esophagectomy. Am J Surg 2001;181:167-71.
52. Sakamoto K, Arakawa H, Mita S, Ishiko T, Ikei S, et al. Elevation of circulating interleukin 6 after surgery: factors inf luencing the serum level. C ytokine 1994;6:181-6.
53. Sato N, Koeda K, Kimura Y, Ikeda K, Ogawa M, et al. Cytokine profile of serum and bronchoalveolar lavage fluids following thoracic esophageal cancer surgery. Eur Surg Res 2001;33:279-84.
54. Tamakuma S, Ogawa M, Aikawa N, Kubota T, Hirasawa H, et al. Relationship between neutrophil elastase and acute lung injury in humans. Pulm Pharmacol Ther 2004;17:271-9.
55. Iba T, Kidokoro A, Fukunaga M, Takuhiro K, Ys ikawa S, et al. Pretreatment of sivelestat sodium hydrate improves the lung microcirculation and alveolar damage in lipopolysaccharide-induced acute lung inflammation in hamsters. Shock 2006;26:95-8.
56. Suda K, Kitagawa Y, Ozawa S, Miyasho T, Okamoto M, et al. Neutrophil elastase inhibitor improves postoperative clinical courses after thoracic esophagectomy. Dis Esophagus 2007;20:478-86.
57. Ono S, Tsujimoto H, Hiraki S, Takahata R, Kimura A, et al. Effects of neutrophil elastase inhibitor on progression of acute lung injury following esophagectomy. World J Surg 2007;31:1996-2001.
58. Akamoto S, Okano K, Sano T, Yachida S, Izuishi K, et al. Neutrophil elastase inhibitor (sivelestat) preserves antitumor immunity and reduces the inflammatory mediators associated with major surgery. Surg Today 2007;37:359-65.
59. Okazumi S, Ochiai T, Shimada H, Matsubara H, Nabeya Y, et al. Development of less invasive surgical procedures for thoracic esophageal cancer. Dis Esophagus 2004;17:159-63.
60. Cuschieri A, Shimi S, Banting S. Endoscopic oesophagectomy through a right thoracoscopic approach. J R Coll Surg Edinb 1992;37:7-11.
61. Akutsu Y, Matsubara H, Hayashi H, Okazumi S, Aoki T, et al. Endoscope-assisted thoracoscopic technique for esophagea l bronchogen ic cyst which presented elevated C A125. Dig Surg 2006;23:209-14.
62. Kawahara K, Maekawa T, Okabayashi K, Hideshima T, Shiraishi T, et al. Video-assisted thoracoscopic esophagectomy for esophageal cancer. Surg Endosc 1999;13:218-23.
63. Zingg U, McQuinn A, DiValentino D, Esterman AJ, Bessell JR, et al. Minimally invasive versus open esophagectomy for patients with esophageal cancer. Ann Thorac Surg 2009;87:911-9.
64. Osugi H, Takemura M, Higashino M, Takada N, Lee S, et al. A comparison of video-assisted thoracoscopic oesophagectomy and radical lymph node dissection for squamous cell cancer of the oesophagus with open operation. Br J Surg 2003;90:108-13.
65. Smithers BM, Gotley DC, Martin I, Thomas JM. Comparison of the outcomes between open and minimally invasive esophagectomy. Ann Surg 2007;245:232-40.
66. Braghetto I, Csendes A, Cardemil G, Burdiles P, Korn O, et al. Open transthoracic or transhiatal esophagectomy versus minimally invasive esophagectomy in terms of morbidity, mortality and survival. Surg Endosc 2006;20:1681-6.
67. Song SY, Na KJ, Oh SG, Ahn BH. Learning curves of minimally invasive esophageal cancer surgery. Eur J Cardiothorac Surg 2009;35:689-93.
68. Osugi H, Takemura M, Higashino M, Takada N, Lee S, et al. Learning curve of video-assisted thoracoscopic esophagectomy and extensive lymphadenectomy for squamous cell cancer of the thoracic esophagus and results. Surg Endosc 2003;17:515-9.
69. Heyland DK, Novak F, Drover JW, Jain M, Su X, et al. Should immunonutrition become routine in critically ill patients? A systematic review of the evidence. JAMA 2001;286:944-53.
70. Heys SD, Walker LG, Smith I, Eremin O. Enteral nutritional supplementation with key nutrients in patients with critical illness and cancer: a meta-analysis of randomized controlled clinical trials. Ann Surg 1999;229:467-77.
71. Beale RJ, Bryg DJ, Bihari DJ. Immunonutrition in the critically ill: a systematic review of clinical outcome. Crit Care Med 1999;27:2799-805.
72. Senkal M, Zumtobel V, Bauer KH, Marpe B, Wolfram G, et al. Outcome and cost-effectiveness of perioperative enteral immunonutrition in patients undergoing elective upper gastrointestinal tract surgery: a prospective randomized study. Arch Surg 1999;34:1309-16.
73. Braga M, Gianotti L, Vignali A, Di Carlo V. Immunonutrition in gastric cancer surgical patients. Nutrition 1998;14:831-5.
74. Takeuchi H, Ikeuchi S, Kawaguchi Y, Kitagawa Y Isobe Y, et al. Clinical significance of perioperative immunonutrition for patients with esophageal cancer World J Surg 2007;31:2160-7. (Pubitemid 47620232)
75. Wilmore DW, Smith RJ, O'Dwyer ST, Jacobs DO Ziegler T R, et al. The gut: a central organ after surgica stress. Surgery 1988;104:917-23.